939 related articles for article (PubMed ID: 23886956)
1. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network.
Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR
Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
[TBL] [Abstract][Full Text] [Related]
3. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
4. Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis.
Lin PY; Simon SM; Koh WK; Folorunso O; Umbaugh CS; Pierce A
Mol Neurodegener; 2013 Nov; 8():43. PubMed ID: 24256636
[TBL] [Abstract][Full Text] [Related]
5. Molecular chaperone mediated late-stage neuroprotection in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Novoselov SS; Mustill WJ; Gray AL; Dick JR; Kanuga N; Kalmar B; Greensmith L; Cheetham ME
PLoS One; 2013; 8(8):e73944. PubMed ID: 24023695
[TBL] [Abstract][Full Text] [Related]
6. Assessment of metal concentrations in the SOD1
Enge TG; Ecroyd H; Jolley DF; Yerbury JJ; Kalmar B; Dosseto A
Mol Cell Neurosci; 2018 Apr; 88():319-329. PubMed ID: 29524628
[TBL] [Abstract][Full Text] [Related]
7. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS).
Crippa V; Sau D; Rusmini P; Boncoraglio A; Onesto E; Bolzoni E; Galbiati M; Fontana E; Marino M; Carra S; Bendotti C; De Biasi S; Poletti A
Hum Mol Genet; 2010 Sep; 19(17):3440-56. PubMed ID: 20570967
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of DJ-1 and PINK1 in sporadic ALS and in the SOD1(G93A) ALS mouse model.
Knippenberg S; Sipos J; Thau-Habermann N; Körner S; Rath KJ; Dengler R; Petri S
J Neuropathol Exp Neurol; 2013 Nov; 72(11):1052-61. PubMed ID: 24128678
[TBL] [Abstract][Full Text] [Related]
9. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model.
Lilo E; Wald-Altman S; Solmesky LJ; Ben Yaakov K; Gershoni-Emek N; Bulvik S; Kassis I; Karussis D; Perlson E; Weil M
Hum Mol Genet; 2013 Dec; 22(23):4720-5. PubMed ID: 23836781
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
13. Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis.
Dupuis L; Mbebi C; Gonzalez de Aguilar JL; Rene F; Muller A; de Tapia M; Loeffler JP
Mol Cell Neurosci; 2002 Feb; 19(2):216-24. PubMed ID: 11860274
[TBL] [Abstract][Full Text] [Related]
14. Elevation of the Hsp70 chaperone does not effect toxicity in mouse models of familial amyotrophic lateral sclerosis.
Liu J; Shinobu LA; Ward CM; Young D; Cleveland DW
J Neurochem; 2005 May; 93(4):875-82. PubMed ID: 15857390
[TBL] [Abstract][Full Text] [Related]
15. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
[TBL] [Abstract][Full Text] [Related]
16. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.
Poon HF; Hensley K; Thongboonkerd V; Merchant ML; Lynn BC; Pierce WM; Klein JB; Calabrese V; Butterfield DA
Free Radic Biol Med; 2005 Aug; 39(4):453-62. PubMed ID: 16043017
[TBL] [Abstract][Full Text] [Related]
17. Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis.
Sábado J; Casanovas A; Hernández S; Piedrafita L; Hereu M; Esquerda JE
J Neuropathol Exp Neurol; 2013 Jul; 72(7):646-61. PubMed ID: 23771221
[TBL] [Abstract][Full Text] [Related]
18. p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis.
Gal J; Ström AL; Kilty R; Zhang F; Zhu H
J Biol Chem; 2007 Apr; 282(15):11068-77. PubMed ID: 17296612
[TBL] [Abstract][Full Text] [Related]
19. A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS.
Nagano S; Takahashi Y; Yamamoto K; Masutani H; Fujiwara N; Urushitani M; Araki T
Hum Mol Genet; 2015 Jun; 24(12):3427-39. PubMed ID: 25762155
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression.
Sharp PS; Akbar MT; Bouri S; Senda A; Joshi K; Chen HJ; Latchman DS; Wells DJ; de Belleroche J
Neurobiol Dis; 2008 Apr; 30(1):42-55. PubMed ID: 18255302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]